PATENT CLAIM ANALYSIS

Application Number: 15906350
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["514", "304000"]

Abstract:
This invention relates to the use of pharmaceutical compositions comprising a therapeutically effective combination of Tesofensine and Metoprolol for preventing the cardiovascular side effects of Tesofensine, while leaving the robust inhibitory efficacy on food intake and body weight loss unaffected.

Claim (Index 13):
The method of  claim 1 , wherein the Metoprolol or the pharmaceutically acceptable salt thereof is administered once daily.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 88.0
- Lexical Diversity: 1.16667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14936963', '14379032', '15058533', '15554449', '13061853']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8007434868918808
- 35 USC 102 Novelty (BERT): 0.6610419636185785
- Combined Prediction Score: 0.7867733345645506
- Mean Citation Score: 486.28498
- Max Citation Score: 738.0185
- Similarity Product: 584.2156123929024

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test